TESARO up 7.5% after rolapitant Phase 3 trial meets primary, secondary endpoints
View todays social media effects on TSRO
View the latest stocks trending across Twitter. Click to view dashboard
View todays social media effects on TSRO
View the latest stocks trending across Twitter. Click to view dashboard